Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study Comparing Ensartinib and Crizotinib for Patients with ALK-Positive Non-Small Cell Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
+1
Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
Not recruiting
Investigated Drugs:
+8
Study comparing brigatinib alone versus brigatinib with carboplatin and pemetrexed combination as first treatment for patients with advanced ALK-positive lung cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on the Safety and Effects of ATL001 and Pembrolizumab in Adults with Advanced Non-Small Cell Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on Lorlatinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer After First-line Treatment Failure
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy
Not recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing Repotrectinib and Crizotinib for Patients with Advanced or Metastatic ROS1-positive Non-Small Cell Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
+4
Study on Atezolizumab, Bevacizumab, and Paclitaxel for Advanced Lung Cancer Patients After Immunotherapy and Chemotherapy
Not recruiting
Investigated Diseases:Investigated Drugs: